BioNexus Gene Lab Corp Common stock (BGLC)

NASDAQ: BGLCUSD
2.21 USD
-0.02 (-1.10%)
AT CLOSE (11:59 AM EDT)
2.25
+0.04 (+1.66%)
POST MARKET (AS OF 07:40 PM EDT)
🔴Market: CLOSED
Open?$2.27
High?$2.27
Low?$2.19
Prev. Close?$2.21
Volume?1.7K
Avg. Volume?6.6K
VWAP?$2.24
Rel. Volume?0.25x
Bid / Ask
Bid?$2.11 × 200
Ask?$2.34 × 200
Spread?$0.23
Midpoint?$2.22
Valuation & Ratios
Market Cap?5.2M
Shares Out?2.4M
Float?1.5M
Float %?63.6%
P/E Ratio?N/A
P/B Ratio?0.77
EPS?-$0.97
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.30Strong
Quick Ratio?6.81Strong
Cash Ratio?1.70Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
0.77CHEAP
P/S?
0.55CHEAP
P/FCF?
N/A
EV/EBITDA?
-1.2CHEAP
EV/Sales?
0.43CHEAP
Returns & Efficiency
ROE?
-33.7%WEAK
ROA?
-30.1%WEAK
Cash Flow & Enterprise
FCF?$-3253989
Enterprise Value?$4.1M
Related Companies
Loading...
News
Profile
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
Employees
1
Market Cap
5.2M
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2020-03-11
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,
KUALA LUMPUR, N8 59200
Phone: 1-307-241-6898